Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 5
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies.
Xu Q, Streuer A, Jann JC, Altrock E, Schmitt N, Flach J, Sens-Albert C, Rapp F, Wolf J, Nowak V, Weimer N, Obländer J, Palme I, Kuzina M, Jawhar A, Darwich A, Weis CA, Marx A, Wuchter P, Costina V, Jäger E, Sperk E, Neumaier M, Fabarius A, Metzgeroth G, Nolte F, Steiner L, Levkin PA, Jawhar M, Hofmann WK, Riabov V, Nowak D. Xu Q, et al. Among authors: schmitt n. Nat Commun. 2023 Mar 17;14(1):1497. doi: 10.1038/s41467-023-37175-8. Nat Commun. 2023. PMID: 36932114 Free PMC article.
ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms.
Riabov V, Xu Q, Schmitt N, Streuer A, Ge G, Bolanos L, Wunderlich M, Jann JC, Wein A, Altrock E, Demmerle M, Mukherjee S, Ali AM, Rapp F, Nowak V, Weimer N, Obländer J, Palme I, Göl M, Jawhar A, Darwich A, Wuchter P, Weiss C, Raza A, Foulks JM, Starczynowski DT, Yang FC, Metzgeroth G, Steiner L, Jawhar M, Hofmann WK, Nowak D. Riabov V, et al. Among authors: schmitt n. Haematologica. 2023 Nov 2. doi: 10.3324/haematol.2023.282921. Online ahead of print. Haematologica. 2023. PMID: 37916386 Free article.
Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium.
Altrock E, Sens-Albert C, Hofmann F, Riabov V, Schmitt N, Xu Q, Jann JC, Rapp F, Steiner L, Streuer A, Nowak V, Obländer J, Weimer N, Palme I, Göl M, Darwich A, Wuchter P, Metzgeroth G, Jawhar M, Hofmann WK, Nowak D. Altrock E, et al. Among authors: schmitt n. Stem Cell Res Ther. 2023 Jun 7;14(1):156. doi: 10.1186/s13287-023-03386-5. Stem Cell Res Ther. 2023. PMID: 37287056 Free PMC article.
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes.
Altrock E, Sens-Albert C, Jann JC, Flach J, Riabov V, Schmitt N, Xu Q, Mehralivand A, Hecht A, Steiner L, Streuer A, Nowak V, Obländer J, Weimer N, Palme I, Jawhar A, Weis CA, Weyer V, Nolte F, Jawhar M, Metzgeroth G, Marx A, Groden C, Hofmann WK, Nowak D. Altrock E, et al. Among authors: schmitt n. Exp Hematol. 2022 Mar;107:38-50. doi: 10.1016/j.exphem.2021.12.395. Epub 2021 Dec 22. Exp Hematol. 2022. PMID: 34952140 Free article.
Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes.
Schmitt N, Jann JC, Altrock E, Flach J, Danner J, Uhlig S, Streuer A, Knaflic A, Riabov V, Xu Q, Mehralivand A, Palme I, Nowak V, Obländer J, Weimer N, Haselmann V, Jawhar A, Darwich A, Weis CA, Marx A, Steiner L, Jawhar M, Metzgeroth G, Boch T, Nolte F, Hofmann WK, Nowak D. Schmitt N, et al. Leukemia. 2022 Jan;36(1):236-247. doi: 10.1038/s41375-021-01327-w. Epub 2021 Jun 25. Leukemia. 2022. PMID: 34172896 Free PMC article.
High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes.
Riabov V, Mossner M, Stöhr A, Jann JC, Streuer A, Schmitt N, Knaflic A, Nowak V, Weimer N, Obländer J, Palme I, Schumann C, Baldus CD, Schulze TJ, Wuchter P, Röhl H, Jawhar A, Weiss C, Boch T, Metzgeroth G, Neumann M, Hofmann WK, Nolte F, Nowak D. Riabov V, et al. Among authors: schmitt n. Br J Haematol. 2021 Mar;192(5):879-891. doi: 10.1111/bjh.17314. Epub 2021 Jan 24. Br J Haematol. 2021. PMID: 33486765
Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.
Jann JC, Mossner M, Riabov V, Altrock E, Schmitt N, Flach J, Xu Q, Nowak V, Obländer J, Palme I, Weimer N, Streuer A, Jawhar A, Darwich A, Jawhar M, Metzgeroth G, Nolte F, Hofmann WK, Nowak D. Jann JC, et al. Among authors: schmitt n. Nat Commun. 2021 Oct 25;12(1):6170. doi: 10.1038/s41467-021-26424-3. Nat Commun. 2021. PMID: 34697318 Free PMC article.
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations.
Flach J, Jann JC, Knaflic A, Riabov V, Streuer A, Altrock E, Xu Q, Schmitt N, Obländer J, Nowak V, Danner J, Mehralivand A, Hofmann F, Palme I, Jawhar A, Wuchter P, Metzgeroth G, Nolte F, Hofmann WK, Nowak D. Flach J, et al. Among authors: schmitt n. Haematologica. 2021 Nov 1;106(11):2906-2917. doi: 10.3324/haematol.2020.254193. Haematologica. 2021. PMID: 33054116 Free PMC article.
11 results